| pubmed-article:11728686 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11728686 | lifeskim:mentions | umls-concept:C0007113 | lld:lifeskim |
| pubmed-article:11728686 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:11728686 | lifeskim:mentions | umls-concept:C0016778 | lld:lifeskim |
| pubmed-article:11728686 | lifeskim:mentions | umls-concept:C1559154 | lld:lifeskim |
| pubmed-article:11728686 | lifeskim:mentions | umls-concept:C1521733 | lld:lifeskim |
| pubmed-article:11728686 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11728686 | pubmed:dateCreated | 2001-11-30 | lld:pubmed |
| pubmed-article:11728686 | pubmed:abstractText | To describe downstaging effects in locally advanced rectal cancer induced by 2 fluopirimidine radiosensitizing agents given through different routes in conjunction with preoperative radiotherapy. | lld:pubmed |
| pubmed-article:11728686 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11728686 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11728686 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11728686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11728686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11728686 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11728686 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11728686 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11728686 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:AlvaradoAA | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:AlvarezEE | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:HerranzRR | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:CalvoF AFA | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:García... | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:MarcosPP | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:Gómez-EspíMM | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:Díaz-González... | lld:pubmed |
| pubmed-article:11728686 | pubmed:author | pubmed-author:Cantalapiedra... | lld:pubmed |
| pubmed-article:11728686 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11728686 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11728686 | pubmed:volume | 51 | lld:pubmed |
| pubmed-article:11728686 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11728686 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11728686 | pubmed:pagination | 1264-70 | lld:pubmed |
| pubmed-article:11728686 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:meshHeading | pubmed-meshheading:11728686... | lld:pubmed |
| pubmed-article:11728686 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11728686 | pubmed:articleTitle | Pathologic downstaging of T3-4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur. | lld:pubmed |
| pubmed-article:11728686 | pubmed:affiliation | Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. | lld:pubmed |
| pubmed-article:11728686 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11728686 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11728686 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
